about
Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema.Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency.Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiencyThe effect of long-term danazol treatment on haematological parameters in hereditary angioedemaGlucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency.A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum."Nuts and Bolts" of Laboratory Evaluation of Angioedema.The role of the complement system in hereditary angioedema.Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1-inhibitor deficiency.Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.Health-related quality of life among children with hereditary angioedema.The relationship between anxiety and quality of life in children with hereditary angioedema.Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack.First report of icatibant treatment in a pregnant patient with hereditary angioedema.Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema.Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedemaManagement of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhoodIdiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary AngioedemaSecreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency
P50
Q34721347-6865E43D-6D32-48E0-94F7-6937D5FC44BCQ36144212-9A151954-32C9-4A6C-83B6-575239C34462Q36361422-9AD916BA-BE3D-4F95-87CF-2F88C3C03CAFQ36616407-CC84CB2C-DC49-49CC-A9A0-248FAC133C24Q37576393-05A2DD5D-5EEB-4ED2-9B31-44408BAE8502Q38746797-E9D43FE1-3F74-41A8-A497-AE7590B6E4B5Q38824626-8B60D9A4-E4A0-465B-AB09-C98E21ED67F3Q39360196-38D6AAC2-0536-4D2E-90B9-D42BC8414F5CQ40567372-25B75D14-BD7B-42FB-B1EA-D57175E25480Q40955998-5564AC2D-FBF0-4647-8DE8-C35071EBFDAFQ43741935-6EA47313-AD6C-4133-BB73-F240F8543214Q47426091-5E31AD1D-F191-4C67-97FD-19AB162C4A0EQ47789438-B31BDE38-4D99-4103-842F-F2EF6CBF3216Q48229275-3FF54115-2BDB-42EE-8C42-49554D4DC5D3Q50907177-5C076B1A-EFBA-4267-8605-CA4B1187F69EQ51141639-97DAA4E2-C0FF-4D13-B014-4B6DE423BE80Q51671149-9E1ADCE3-B59F-416C-849C-D454BE1E4DA3Q53973386-EA7A6AD5-A774-4C0F-B68A-5AE1D6BDEA03Q86122313-A372CF1C-D4DB-49E8-AEA1-5EE6B6F42E2FQ88063185-7A887A0F-23F0-4C3E-9FCF-C9EABD25C0AFQ88532453-18D5C3E1-C5A2-4967-9A47-16E3943D395AQ90790386-6DE10C04-BAF5-448B-A8ED-175D962B8A12
P50
description
investigador
@es
researcher
@en
name
Nora Veszeli
@en
type
label
Nora Veszeli
@en
prefLabel
Nora Veszeli
@en
P31
P496
0000-0002-7647-2173